NOBEL BIOCARE DANMARK A/S
CVR 28293364 · Public limited company (A/S) · Active · Low risk
NOBEL BIOCARE DANMARK A/S is a Public limited company (A/S), founded on , based in Silkeborg. The company is registered in the industry fremstilling af medicinske og dentale instrumenter samt udstyr hertil. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 20 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -11.0m and a net result of DKK -4.8m.
Bankruptcy risk for NOBEL BIOCARE DANMARK A/S
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 28293364
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (21 years)
- Address
- c/o Jan Jerne, Sindbjergvej 3A
8600 Silkeborg - Municipality
- Silkeborg
- Industry
- Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)
Bankruptcies in the industry: Fremstilling af medicinske og dentale instrumenter samt udstyr hertil - Share capital
- DKK 500k
- Employees
- 3 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 21 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -9.6% |
| Current ratio | 78% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 17 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 4.0m | DKK 3.8m | DKK 3.1m |
| Net profit | DKK -4.8m | DKK -4.5m | DKK -2.0m |
| Equity | DKK -11.0m | DKK -6.1m | DKK -1.6m |
| Total assets | DKK 113.9m | DKK 160.0m | DKK 154.5m |
| Short-term debt | DKK 124.9m | DKK 166.2m | – |
| Tax owed | DKK 594k | DKK 465k | – |
| Avg. employees | 3 | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 182 | ||
| 1 Jan 2024 – 31 Dec 2024 | 171 | ||
| 1 Jan 2023 – 31 Dec 2023 | 178 | ||
| 1 Jan 2022 – 31 Dec 2022 | 178 | ||
| 1 Jan 2021 – 31 Dec 2021 | 255 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 200 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 246 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 162 | ||
| 1 Jan 2017 – 31 Dec 2017 | 162 | ||
| 1 Jan 2016 – 31 Dec 2016 | 166 | ||
| 1 Jan 2015 – 31 Dec 2015 | 183 | ||
| 1 Jan 2014 – 31 Dec 2014 | 152 | ||
| 1 Jan 2013 – 31 Dec 2013 | 151 | ||
| 1 Jan 2012 – 31 Dec 2012 | 155 | ||
| 1 Jan 2011 – 31 Dec 2011 | 169 | ||
| 1 Jan 2010 – 31 Dec 2010 | 149 | ||
| 1 Jan 2009 – 31 Dec 2009 | 153 | ||
| 1 Jan 2008 – 31 Dec 2008 | 159 | ||
| 1 Jan 2007 – 31 Dec 2007 | 169 | ||
| 1 Jan 2006 – 31 Dec 2006 | 149 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Karl Magnus Persson | ||
| CEO | Nils Thomas Göran Nortoft | ||
| CEO | Kjell Ove Jonsson | ||
| CEO | Sven Wissing Jensen | ||
| CEO | Jan Jerne | ||
| CEO | Jens Henrik Nedoh | ||
| CEO | Hans Braunstein | ||
| CEO | Lars Fredrik Strömberg | ||
| CEO | Lars Fredrik Strömberg | ||
| Board | Magnus Karl Andreas Pettersson | Current | |
| Board | Harrieth Eva Elisabeth Sundaeus | Current | |
| Board | Jan Jerne | Current | |
| Board | Barbro Michaela Ahlberg | ||
| Board | Karl Magnus Persson | ||
| Board | Thomas Fritz Bögli | ||
| Board | Jan Lars Robert Gottlander | ||
| Board | Åsa Camilla Elisabeth Johnson | ||
| Board | Jacques Claude Gutedel | ||
| Board | Harrieth Eva Elisabeth Sundaeus | ||
| Board | Alexander Johannes Ochsner | ||
| Board | Karl Magnus Persson | ||
| Board | Hans Tobias Nordefjäll | ||
| Board | Jens Henrik Nedoh | ||
| Board | Magnus K. Andreas Pettersson | ||
| Board | Hans Braunstein | ||
| Board | Lars Fredrik Strömberg | ||
| Board | Lars Fredrik Strömberg | ||
| Board | Chris James Stahle | ||
| Board | Stefan Fabian Lieb | ||
| Board | Peter Esbjörn Rådqvist | ||
| Owner (100%) | Nobel Biocare AB | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | CJ Partnership I/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Founder | Nobel Biocare Norden AB | Current |
Address history (3 moves)
| c/o Jan Jerne, Sindbjergvej 3A, 8600 Silkeborg | |
| c/o Ernst & Young, Milnersvej 43, 3400 Hillerød | |
| Klampenborgvej 232, 2., 2800 Kgs. Lyngby | |
| Strandvejen 130, 2900 Hellerup |
Employees per year
Similar companies in Silkeborg
- Silkeborg Tandteknik ApS Silkeborg
- LG Holding af 2016 ApS Silkeborg
- Tandstudiet ApS Silkeborg
- EASY DENT A/S Silkeborg
- Senzone ApS Silkeborg
- PRO DENTAL ApS Silkeborg
- Ffeluorg ApS Silkeborg
- PTL A/S Silkeborg
- DESIGN DENTAL ApS Silkeborg
- MØRKBAK DENTAL ApS Silkeborg
- PRÆCEDENS ApS Silkeborg
- Selskabet af 30. januar 2018 ApS Silkeborg
Questions and answers about NOBEL BIOCARE DANMARK A/S
Has NOBEL BIOCARE DANMARK A/S gone bankrupt?
No, NOBEL BIOCARE DANMARK A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NOBEL BIOCARE DANMARK A/S?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the auditor of NOBEL BIOCARE DANMARK A/S?
NOBEL BIOCARE DANMARK A/S most recently used EY Godkendt Revisionspartnerselskab.
When was NOBEL BIOCARE DANMARK A/S founded?
NOBEL BIOCARE DANMARK A/S was founded on 24 November 2004.
What is the equity of NOBEL BIOCARE DANMARK A/S?
Equity was DKK -11.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.